Independent research on the U.S. markets, Baptista Research

Baptista Research

Independent research on the U.S. markets

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

Equity Bottom-Up

<ul><li>The Clorox Company managed to exceed the revenue expectations as well as the earnings expectations of Wall Street.</li><li>Clorox's performance aligned with expectations preceding the cyber-attack in August, showcasing strong consumption and market share trends.</li><li>In this report, we have carried out a fundamental analysis of the historical financial statements of the company.</li></ul>

The Clorox Company managed to exceed the revenue expectations as well as the earnings expectations of Wall Street.Clorox's performance aligned with expectations preceding the cyber-attack in August, showcasing strong consumption and market share trends.In this report, we have carried out a fundamental analysis of the historical financial statements of the company.

The Clorox Company: Managing Supply Chain Inflation and Gross Margins! - Major Drivers

<ul><li>The Clorox Company managed to exceed analyst expectations in terms of revenue and earnings.</li><li>Strong results at the quarter's end highlight the tremendous progress the company has made with its strategic priorities.</li><li>In this report, we have carried out a fundamental analysis of the historical financial statements of the company.</li></ul>

The Clorox Company managed to exceed analyst expectations in terms of revenue and earnings.Strong results at the quarter's end highlight the tremendous progress the company has made with its strategic priorities.In this report, we have carried out a fundamental analysis of the historical financial statements of the company.

The Clorox Company: Unmasking Their Strategy to Restore Pre-Pandemic Margins! - Major Drivers

<ul><li>Despite a difficult operational and cost environment, Clorox produced solid results in the third quarter, managing an all-around beat, with organic sales growth in each of its 4 businesses, an increase in gross margin, and double-digit adjusted EPS growth.</li><li>Clorox made excellent strides throughout the quarter by increasing margin while sustaining top-line growth.</li><li>Clorox also experienced an increase in gross margin, helped by cost-justified pricing and cost reductions that reached a decade-high level.</li></ul>

Despite a difficult operational and cost environment, Clorox produced solid results in the third quarter, managing an all-around beat, with organic sales growth in each of its 4 businesses, an increase in gross margin, and double-digit adjusted EPS growth.Clorox made excellent strides throughout the quarter by increasing margin while sustaining top-line growth.Clorox also experienced an increase in gross margin, helped by cost-justified pricing and cost reductions that reached a decade-high level.

The Clorox Company: Launch of Start Clean & Other Developments

Technical Analyst, Vermilion Research

Joe Jasper

Technical Analyst

Technical and Quantitative Research

Vermilion Research

Vermilion’s objective is to deliver timely, actionable, and unique technical research to professional investors through the application of our various technical indicators.

Our research strategists seek to highlight securities which we believe are at major inflection points, based on our various technical and quantitative indicators, and offer asymmetric risk/return profiles. Our unique research methodology, centered on relative strength, enables our strategists to deliver superior investment recommendations.

Our process begins by organizing the universe of actively traded stocks into discrete sectors, then into industry groups. We then apply our technical and quantitative tools to identify developing price trends. Once attractive trends are identified within a selected sector or group, we screen for individual stocks which we believe offer the best risk/reward profile. We provide a historical perspective that often reveals, through our long-term charts, how price patterns often repeat themselves over time.

Technical Analysis

<ul>
<li>Last week we discussed potential for a 2-5% rally to the 1.5-month downtrend on SPX, or even the 4165-4200 range, which would set up an opportunity to get more defensive.</li>
<li>As long as the S&amp;P 500 is below Wednesdays high of 4040 we continue to believe the bears are in control -- stay defensive.</li>
<li>Even if there is a reversal, we still expect 4165-4200 on SPX to cap upside for 2023. We highlight many buy opportunities within Consumer Staples</li>
</ul>


Last week we discussed potential for a 2-5% rally to the 1.5-month downtrend on SPX, or even the 4165-4200 range, which would set up an opportunity to get more defensive.
As long as the S&amp;P 500 is below Wednesdays high of 4040 we continue to believe the bears are in control -- stay defensive.
Even if there is a reversal, we still expect 4165-4200 on SPX to cap upside for 2023. We highlight many buy opportunities within Consumer Staples


S&P 500, Nasdaq 100, DJIA All Testing Resistance; Downgrading Financials to Underweight; Buy Staples

<ul><li>Clorox delivered a solid set of results in the previous quarter with organic sales growth in 3 to 4 segments, double-digit earnings growth, and gross margin expansion, despite the challenges in the market due to an unstable global operating environment.</li><li>The company delivered an all-around beat and continued to work on the enhancement of its brand equity.</li><li>Clorox has been encountering different challenges in the macro environment for the past few quarters especially after the Covid-19 tailwinds have receded.</li></ul>

Clorox delivered a solid set of results in the previous quarter with organic sales growth in 3 to 4 segments, double-digit earnings growth, and gross margin expansion, despite the challenges in the market due to an unstable global operating environment.The company delivered an all-around beat and continued to work on the enhancement of its brand equity.Clorox has been encountering different challenges in the macro environment for the past few quarters especially after the Covid-19 tailwinds have receded.

United States

The Clorox Company produces and markets non-durable consumer products sold primarily through grocery and other retail stores.  The Company's principal products include household cleaning and bleach products, charcoal, cat litter, automotive care products, dressings, and trash bags.  Clorox markets its products in the United States and other countries around the world.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Clorox Company (CLX US)

The Clorox Company: Managing Supply Chain Inflation and Gross Margins! - Major Drivers

The Clorox Company managed to exceed the revenue expectations as well as the earnings expectations of Wall Street. Clorox's performance aligned...

Baptista Research

The Clorox Company: Unmasking Their Strategy to Restore Pre-Pandemic Margins! - Major Drivers

The Clorox Company managed to exceed analyst expectations in terms of revenue and earnings. Strong results at the quarter's end highlight the...

Baptista Research

The Clorox Company: Launch of Start Clean & Other Developments

Despite a difficult operational and cost environment, Clorox produced solid results in the third quarter, managing an all-around beat, with...

Baptista Research

S&P 500, Nasdaq 100, DJIA All Testing Resistance; Downgrading Financials to Underweight; Buy Staples

Last week (3/21) we discussed the potential for a 2-5% rally to the 1.5-month downtrend on the $SPX, or even the 4165-4200 range, which we noted...

Vermilion Research

The Clorox Co: Major Drivers

Clorox delivered a solid set of results in the previous quarter with organic sales growth in 3 to 4 segments, double-digit earnings growth, and...

Baptista Research

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)